Advertisement
U.S. markets close in 4 hours 27 minutes
  • S&P 500

    5,254.61
    +6.12 (+0.12%)
     
  • Dow 30

    39,775.97
    +15.89 (+0.04%)
     
  • Nasdaq

    16,404.89
    +5.37 (+0.03%)
     
  • Russell 2000

    2,126.87
    +12.52 (+0.59%)
     
  • Crude Oil

    82.67
    +1.32 (+1.62%)
     
  • Gold

    2,235.90
    +23.20 (+1.05%)
     
  • Silver

    25.00
    +0.25 (+1.00%)
     
  • EUR/USD

    1.0805
    -0.0025 (-0.23%)
     
  • 10-Yr Bond

    4.1910
    -0.0050 (-0.12%)
     
  • dólar/libra

    1.2637
    -0.0001 (-0.01%)
     
  • USD/JPY

    151.2070
    -0.0390 (-0.03%)
     
  • Bitcoin USD

    71,187.34
    +2,169.88 (+3.14%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,970.26
    +38.28 (+0.48%)
     
  • Nikkei 225

    40,168.07
    -594.66 (-1.46%)
     

AMAG Pharmaceuticals: 4Q Earnings Snapshot

AMAG Pharmaceuticals: 4Q Earnings Snapshot

WALTHAM, Mass. (AP) _ AMAG Pharmaceuticals Inc. (AMAG) on Thursday reported a fourth-quarter loss of $22.3 million, after reporting a profit in the same period a year earlier.

The Waltham, Massachusetts-based company said it had a loss of 64 cents per share. Losses, adjusted to account for discontinued operations, were 60 cents per share.

The results beat Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 98 cents per share.

The specialty drugmaker posted revenue of $88.1 million in the period, missing Street forecasts. Three analysts surveyed by Zacks expected $90.1 million.

For the year, the company reported that its loss narrowed to $65.8 million, or $1.91 per share. Revenue was reported as $474 million.

AMAG Pharmaceuticals expects full-year revenue in the range of $365 million to $415 million.

AMAG Pharmaceuticals shares have risen roughly 7 percent since the beginning of the year. The stock has increased 19 percent in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AMAG at https://www.zacks.com/ap/AMAG

Advertisement